Document/ExhibitDescriptionPagesSize 1: 8-K/A Amendment to Current Report HTML 29K
2: EX-99.1 Miscellaneous Exhibit HTML 252K
6: R1 Cover Page HTML 49K
8: XML IDEA XML File -- Filing Summary XML 11K
11: XML XBRL Instance -- shc-20240502_htm XML 15K
7: EXCEL IDEA Workbook of Financial Report Info XLSX 8K
4: EX-101.LAB XBRL Labels -- shc-20240502_lab XML 66K
5: EX-101.PRE XBRL Presentations -- shc-20240502_pre XML 35K
3: EX-101.SCH XBRL Schema -- shc-20240502 XSD 10K
9: JSON XBRL Instance as JSON Data -- MetaLinks 12± 18K
10: ZIP XBRL Zipped Folder -- 0001822479-24-000017-xbrl Zip 40K
(Address of Principal Executive Offices) (Zip Code)
(i440)
i262-1410
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
_______________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
i☐
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
i☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
i☐
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
i☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title
of Each Class
Trading
Symbol
Name of Exchange
on which registered
iCommon stock, $0.01 par value per share
iSHC
iThe
Nasdaq Stock Market LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2).
Emerging growth company i☐
If an emerging growth company, indicate by check mark if the registrant has
elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Explanatory Note.
iThis
Amendment to Current Report on Form 8-K (the “Amendment”) is being filed as an amendment to the Current Report on Form 8-K filed by Sotera Health Company (the “Company”) with the United States Securities and Exchange Commission on May 2, 2024 (the “Original Form 8-K”). The Company is filing this Amendment solely to correct a typographical error in the Exhibit 99.1, page 6, Consolidated Statements of Operations, which erroneously included the line "Impairment of long-lived assets." The error had no impact on "Total operating expenses,""Income before income taxes," or "Net income" for the three months ended March 31, 2024.
Item 2.02. Results
of Operations and Financial Condition.
The information in this Item 2.02, including Exhibit 99.1, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to liability under that section, and shall not be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, unless expressly incorporated by specific reference in such filing.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
